| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/2009 | EP2099433A2 Modified release ibuprofen solid oral dosage form |
| 09/16/2009 | EP2099432A2 Method of forming a tablet comprising pre-blend of ibuprofen and silicon dioxide |
| 09/16/2009 | EP2099431A2 Stabilized solid pharmaceutical composition of candesartan cilexetil |
| 09/16/2009 | EP2099430A2 Ph sensitive matrix formulation |
| 09/16/2009 | EP2099408A2 Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics |
| 09/16/2009 | EP2099387A2 Intraocular drug delivery systems |
| 09/16/2009 | EP2099360A2 Myocardial perfusion imaging |
| 09/16/2009 | EP2099303A1 Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy |
| 09/16/2009 | EP2099300A1 Il-8 receptor antagonists |
| 09/16/2009 | EP2099299A2 Oxazolidinone derivatives and methods of use |
| 09/16/2009 | EP2099298A1 Crystalline and amorphous forms of palonosetron hydrochloride |
| 09/16/2009 | EP1988924B1 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition |
| 09/16/2009 | EP1987025B1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
| 09/16/2009 | EP1960371B1 Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase |
| 09/16/2009 | EP1910383B1 Benzodiazepine derivatives and uses thereof in medical field |
| 09/16/2009 | EP1893237B1 Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle |
| 09/16/2009 | EP1893185B1 USE OF UROKINASE INHIBITORS FOR THE TREATMENT AND/OR PREVENTION OF AMYOTROPhIC LATERAL SCLEROSIS (ALS) |
| 09/16/2009 | EP1891961B1 Use of 5'-methylthioadenosine (mta) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection |
| 09/16/2009 | EP1858865B1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds |
| 09/16/2009 | EP1828184B1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases |
| 09/16/2009 | EP1817029B1 Isoxazolic derivative to relieve neuropathic pain |
| 09/16/2009 | EP1765323B1 Use of furan alkyl for preparing an antidiabetic drug |
| 09/16/2009 | EP1737450B1 Aqueous composition comprising a thiazole derivative |
| 09/16/2009 | EP1706106B9 Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances |
| 09/16/2009 | EP1684728B1 Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate |
| 09/16/2009 | EP1651214B1 Benzimidazole derivatives as mek inhibitors |
| 09/16/2009 | EP1631252B1 Method for producing a solid pharmaceutical composition |
| 09/16/2009 | EP1608635B1 Phenyl sulfone derivatives and their use in the treatment of cns disorders |
| 09/16/2009 | EP1585515B1 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor |
| 09/16/2009 | EP1581488B1 Inhibitors of tace |
| 09/16/2009 | EP1578737B1 Substituted heterocyclic compounds |
| 09/16/2009 | EP1564210B1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 09/16/2009 | EP1562897B1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1486500B1 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacteria |
| 09/16/2009 | EP1478656B1 Oligonucleotide compositions with enhanced efficiency |
| 09/16/2009 | EP1478364B1 Selective antibacterial agents |
| 09/16/2009 | EP1472541B1 Imaging agents and methods of imaging naaladase of psma |
| 09/16/2009 | EP1419149B1 Benzo[g]quinoline derivatives for treating glaucoma and myopia |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1411046B1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | EP1254238B1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 09/16/2009 | EP1192125B9 Mono-substituted 3-propyl gamma-aminobutyric acids |
| 09/16/2009 | EP1169021B1 Compositions and methods for treating lymphoma |
| 09/16/2009 | EP1153601B1 Skin preparations for external use |
| 09/16/2009 | EP1083899B1 Derivatives of 1-deoxy-galactonojirimycin and their use in the treatment of lysosomal storage diseases by enhancing lysosomal alpha-galactosidase a |
| 09/16/2009 | EP1027443B1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 09/16/2009 | EP0975595B9 Analogs of cocaine |
| 09/16/2009 | EP0941087B1 Topical formulations containing as a therapeutic active agent a monoglyceride for treating of mucosa infections |
| 09/16/2009 | CN101534852A Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 09/16/2009 | CN101534843A Use of poloxamer for the prevention and/or treatment of heart failure |
| 09/16/2009 | CN101534842A Composition comprising hyaluronic acid and/or its salts for treatment of atopic dermatitis |
| 09/16/2009 | CN101534841A AMPK potentiator containing chito-oligosaccharide |
| 09/16/2009 | CN101534840A Methods for the treatment of radiation proctosigmoitis |
| 09/16/2009 | CN101534839A Antioxidant for preventing and treating diseases caused by oxidative stress |
| 09/16/2009 | CN101534838A Use of c7 sugars in prevention and treatment of mycoses |
| 09/16/2009 | CN101534837A Azithromycin for the treatment of nodular acne |
| 09/16/2009 | CN101534836A Inhibition of fatty acid synthesis by PARP inhibitors and methods of treatment thereof |
| 09/16/2009 | CN101534835A L-OddC prodrugs for cancer |
| 09/16/2009 | CN101534834A Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin d or its derivative and bisphosphonate |
| 09/16/2009 | CN101534833A Nicotinic desensitizers and methods of selecting, testing, and using them |
| 09/16/2009 | CN101534832A Nitrogen containing substituted heterocycles as platelet ADP receptor inhibitors |
| 09/16/2009 | CN101534831A Tyrosine kinase inhibitors containing a zinc binding moiety |
| 09/16/2009 | CN101534830A Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain |
| 09/16/2009 | CN101534829A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 09/16/2009 | CN101534828A Allosteric modulators of the A1 adenosine receptor |
| 09/16/2009 | CN101534827A Dosage forms and co-administration of an opioid agonist and an opioid antagonist |
| 09/16/2009 | CN101534826A Method of treatment of age-related macular degeneration(amd) |
| 09/16/2009 | CN101534825A Drug formulation containing fibrate medicament and process for producing the same |
| 09/16/2009 | CN101534824A Aminopyrrolidines as chemokine receptor antagonists |
| 09/16/2009 | CN101534823A Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 09/16/2009 | CN101534822A Treating pain, diabetes, and disorders of lipid metabolism |
| 09/16/2009 | CN101534821A Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
| 09/16/2009 | CN101534820A N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 09/16/2009 | CN101534819A Methods for enhancing cognitive function |
| 09/16/2009 | CN101534818A Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 09/16/2009 | CN101534817A Use for treating obesity and diabetes |
| 09/16/2009 | CN101534816A External composition for skin containing manassantin B as active ingredient and the use thereof for skin whitening |
| 09/16/2009 | CN101534815A Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions |
| 09/16/2009 | CN101534814A Therapeutic compounds for diseases and disorders |
| 09/16/2009 | CN101534813A Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 09/16/2009 | CN101534812A Use of L-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases |
| 09/16/2009 | CN101534811A Compounds with medicinal effects due to interaction with the glucocorticoid receptor |
| 09/16/2009 | CN101534810A Antiinflammatory agent comprising 2-aminophenol or derivative thereof as active ingredient |
| 09/16/2009 | CN101534809A Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain |
| 09/16/2009 | CN101534808A Modified-release formulations of a bupropion salt |
| 09/16/2009 | CN101534807A Pharmaceutical and nutraceutical products comprising vitamin k2 |
| 09/16/2009 | CN101534806A Method of treating asthma, allergic rhinitis, and skin disorders |
| 09/16/2009 | CN101534805A Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same |
| 09/16/2009 | CN101532997A Production control of platinum-based anti-cancer drugs and method for measuring micro silver in product |
| 09/16/2009 | CN101532994A A method for measuring the content of a brain-invigorating and kidney-tonifying preparation |
| 09/16/2009 | CN101532013A RNA for inhibiting Hepcidin, recombinant and application |
| 09/16/2009 | CN101531697A Method for preparing sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and novel pharmaceutical application of the sarsasapogenin in the rhizoma anemarrhenae and the derivatives thereof |
| 09/16/2009 | CN101531696A Application of steroid saponin terpenoids and derivatives thereof in preparing medicine for treating purine metabolic disturbance diseases |
| 09/16/2009 | CN101531691A Triazole glucoside, method for synthesizing same by enzyme chemical method and application thereof |
| 09/16/2009 | CN101531682A Metal coordination complex and method for preparing same |
| 09/16/2009 | CN101531657A Dimethyldiguanide of the thiazolidinedione pharmaceutical, preparation method and use thereof |